In summary, this study describes for the first time the over-expression of DNMT3B gene in RMS primary tumours and cell lines, suggesting that an aberrant transcriptional control mediated by this de novo DNMT is a key event in RMS development and progression. The gene discussed is DNMT3B; the disease is neoplasm.